Treatment of COVID-19 : implications for antimicrobial resistance in Africa
| dc.contributor.author | Iwu, Chinwe Juliana | |
| dc.contributor.author | Jordan, Portia | |
| dc.contributor.author | Jaja, Ishmael Festus | |
| dc.contributor.author | Iwu, Chidozie Declan | |
| dc.contributor.author | Wiysonge, Charles Shey | |
| dc.date.accessioned | 2021-07-15T11:51:04Z | |
| dc.date.available | 2021-07-15T11:51:04Z | |
| dc.date.issued | 2020-07-20 | |
| dc.description.abstract | There is currently no approved pharmaceutical product for the treatment of COVID-19. However, antibiotics are currently being used for the management of COVID-19 patients in many settings either treat to coinfections or for the treatment of COVID-19 itself. In this commentary, we highlight that the increased rates of antimicrobial prescribing for COVID-19 patients could further worsen the burden of antimicrobial resistance (AMR). We also highlight that though AMR is a global threat, Africa tends to suffer most from the consequences. We, therefore, call on African countries not to lose sight of the possible implications of the treatment of COVID-19 on AMR and a need to redouble efforts towards the fight against AMR while dealing with the pandemic. | en_ZA |
| dc.description.department | School of Health Systems and Public Health (SHSPH) | en_ZA |
| dc.description.librarian | am2021 | en_ZA |
| dc.description.uri | http://www.panafrican-med-journal.com | en_ZA |
| dc.identifier.citation | Iwu, C.J., Jordan, P., Jaja, I.F., Iwu, C.D. Treatment of COVID-19: implications for antimicrobial resistance in Africa. Pan Africa Medical Journal. 2020;35(2):119 DOI: 10.11604/pamj.supp.2020.35.23713. | en_ZA |
| dc.identifier.issn | 1937-8688 (online) | |
| dc.identifier.other | 10.11604/pamj.supp.2020.35.23713 | |
| dc.identifier.uri | http://hdl.handle.net/2263/80864 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | African Field Epidemiology Network | en_ZA |
| dc.rights | © Chinwe Juliana Iwu et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License. | en_ZA |
| dc.subject | Africa | en_ZA |
| dc.subject | COVID-19 pandemic | en_ZA |
| dc.subject | Coronavirus disease 2019 (COVID-19) | en_ZA |
| dc.subject | Antimicrobial resistance (AMR) | en_ZA |
| dc.subject | Treatment | en_ZA |
| dc.title | Treatment of COVID-19 : implications for antimicrobial resistance in Africa | en_ZA |
| dc.type | Article | en_ZA |